Ashland Specialty Ingredients has opened a pharmaceutical center of excellence in Wilmington, DE focused on drug development and bioavailability enhancement, expanding the company’s global network of R&D centers. The facility also offers formulation and contract development for solid dispersions and oral solid-dosage forms. For early stage proof-of concept-studies, capabilities include spray drying, hot-melt extrusion and potent-compound processing suites.   “A key commitment is to be close ...